Dressen; Darren B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dressen; Darren B..The latest application filed is for "heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4".

Company Profile

0.29.32

Dressen; Darren B. - San Francisco CA
Dressen; Darren B. - San Mateo CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 7,973,044 - Konradi , et al. July 5, 2	2011-07-05
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 7,968,547 - Konradi , et al. June 28, 2	2011-06-28
Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 Grant 7,745,454 - Konradi , et al. June 29, 2	2010-06-29
Heteroaryl, Heterocyclic And Aryl Compounds Which Inhibit Leukocyte Adhesion Mediated By Vla-4 App 20100160341 - Konradi; Andrei W. ; et al.	2010-06-24
Heteroaryl, Heterocyclic And Aryl Compounds Which Inhibit Leukocyte Adhesion Mediated By Vla-4 App 20100160343 - Konradi; Andrei W. ; et al.	2010-06-24
Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents Grant 7,576,101 - Karlik , et al. August 18, 2	2009-08-18
Substituted pyrazole derivatives and related compounds as bradykinin B.sub.1 receptor antagonists Grant 7,432,379 - Tung , et al. October 7, 2	2008-10-07
4-bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid amide derivatives and related compounds as bradykinin B.sub.1 receptor antagonists for the treatment of inflammatory diseases Grant 7,417,152 - Tung , et al. August 26, 2	2008-08-26
3-(heteroaryl)alanine Derivatives-inhibitors Of Leukocyte Adhesion Mediated By Vla-4 App 20080182850 - Konradi; Andrei W. ; et al.	2008-07-31
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 7,378,529 - Konradi , et al. May 27, 2	2008-05-27
3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 Grant 7,365,073 - Konradi , et al. April 29, 2	2008-04-29
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 7,320,960 - Thorsett , et al. January 22, 2	2008-01-22
Phenylalanine derivatives as alpha 4 integrin inhibitors Grant 7,291,645 - Konradi , et al. November 6, 2	2007-11-06
Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 7,288,526 - Thorsett , et al. October 30, 2	2007-10-30
4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases App 20070161633 - Tung; Jay S. ; et al.	2007-07-12
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 7,229,970 - Thorsett , et al. June 12, 2	2007-06-12
4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases App 20070123531 - Garofalo; Albert W. ; et al.	2007-05-31
Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 Grant 7,223,762 - Konradi , et al. May 29, 2	2007-05-29
Compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 7,166,580 - Dappen , et al. January 23, 2	2007-01-23
4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carvoxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases App 20060281733 - Tung; Jay S. ; et al.	2006-12-14
Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 7,101,855 - Dressen , et al. September 5, 2	2006-09-05
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. Grant 7,049,306 - Konradi , et al. May 23, 2	2006-05-23
Compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 7,030,114 - Thorsett , et al. April 18, 2	2006-04-18
Heteroaryl-.beta.-alanine derivatives as alpha 4 integrin inhibitors Grant 7,015,216 - Konradi , et al. March 21, 2	2006-03-21
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 7,005,433 - Konradi , et al. February 28, 2	2006-02-28
Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 Grant 6,953,802 - Konradi , et al. October 11, 2	2005-10-11
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20050222119 - Thorsett, Eugene D. ; et al.	2005-10-06
Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents App 20050215565 - Karlik, Stephen J. ; et al.	2005-09-29
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20050203093 - Konradi, Andrei W. ; et al.	2005-09-15
Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 App 20050192280 - Konradi, Andrei W. ; et al.	2005-09-01
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 6,911,439 - Konradi , et al. June 28, 2	2005-06-28
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 6,900,179 - Thorsett , et al. May 31, 2	2005-05-31
Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 App 20050085459 - Konradi, Andrei W. ; et al.	2005-04-21
Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents App 20050069541 - Karlik, Stephen J. ; et al.	2005-03-31
Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists App 20050038099 - Tung, Jay S. ; et al.	2005-02-17
Selected substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists App 20050032868 - Garofalo, Albert W. ; et al.	2005-02-10
Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists App 20050020659 - Tung, Jay S. ; et al.	2005-01-27
3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 App 20040266763 - Konradi, Andrei W. ; et al.	2004-12-30
Alpha amino acid derivatives--inhibitors of leukocyte adhesion mediated by VLA-4 Grant 6,803,370 - Konradi , et al. October 12, 2	2004-10-12
3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 Grant 6,794,506 - Konradi , et al. September 21, 2	2004-09-21
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20040147512 - Konradi, Andrei W. ; et al.	2004-07-29
Phenylalanine derivatives as alpha 4 integrin inhibitors App 20040127486 - Konradi, Andrei W. ; et al.	2004-07-01
Phenylalanine derivatives as alpha 4 integrin inhibitors Grant 6,689,781 - Konradi , et al. February 10, 2	2004-02-10
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20040014677 - Thorsett, Eugene D. ; et al.	2004-01-22
Compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20030166575 - Dappen, Michael S. ; et al.	2003-09-04
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated byVLA-4 App 20030139402 - Konradi, Andrei W. ; et al.	2003-07-24
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20030125324 - Konradi, Andrei W. ; et al.	2003-07-03
Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 6,586,602 - Thorsett , et al. July 1, 2	2003-07-01
Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20030065193 - Thorsett, Eugene D. ; et al.	2003-04-03
Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20030065185 - Thorsett, Eugene D. ; et al.	2003-04-03
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 6,525,026 - Thorsett , et al. February 25, 2	2003-02-25
Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20030027771 - Dressen, Darren B. ; et al.	2003-02-06
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20030017993 - Thorsett, Eugene D. ; et al.	2003-01-23
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20020193312 - Thorsett, Eugene D. ; et al.	2002-12-19
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 6,492,372 - Konradi , et al. December 10, 2	2002-12-10
Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 6,492,421 - Thorsett , et al. December 10, 2	2002-12-10
Heteroaryl-beta-alanine derivatives as alpha 4 integrin inhibitors App 20020086882 - Konradi, Andrei W. ; et al.	2002-07-04
Beta-amino acid derivatives--inhibitors of leukocyte adhesion mediated by VLA-4 App 20020058664 - Konradi, Andrei W. ; et al.	2002-05-16
Phenylalanine derivatives as alpha 4 integrin inhibitors App 20020055509 - Konradi, Andrei W. ; et al.	2002-05-09
3-(Heteroaryal) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 App 20020052375 - Konradi, Andrei W. ; et al.	2002-05-02
Alpha amino acid derivatives--inhibitors of leukocyte adhesion mediated by VLA-4 App 20020052470 - Konradi, Andrei W. ; et al.	2002-05-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.